Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Kangpu Biopharmaceuticals divulges CRBN-binding isoindolines

Aug. 16, 2021

MedImmune patents new ADCs for cancer

Aug. 16, 2021

SSAO inhibitors identified at Shanghai Ennova Biopharmaceutical, Ennovabio Pharmaceuticals

Aug. 13, 2021

Shanghai Hengrui Pharmaceutical and others patent ADCs with eribulin derivatives

Aug. 13, 2021

Shenzhen Salubris Pharmaceuticals presents new cathepsin K inhibitors

Aug. 13, 2021

B-Raf, MEK1 inhibitors discovered at Chugai

Aug. 13, 2021

Nuvation Bio identifies new adenosine A2a receptor antagonists

Aug. 12, 2021

New PTPN11 inhibitors discovered at Betta Pharmaceuticals

Aug. 12, 2021

Jiangsu Hengrui Medicine and collaborators patent antibacterials

Aug. 12, 2021

Janssen describes mutant FimH compositions

Aug. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...